Dow and Dow Corning Present Latest Technologies for Drug Delivery at AAPS 2016

Denver, COLORADO - November 10, 2016 - Dow and Dow Corning are presenting their latest innovative technologies and breakthroughs for the pharmaceutical industry here at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, Nov. 13-16, 2016. This year’s event marks the first joint appearance at AAPS by the Dow and Dow Corning teams since Dow became 100 percent owner of Dow Corning’s silicones business on June 1, 2016.

Dow Corning is introducing Dow Corning® SilAc Hybrid Pressure Sensitive Adhesives (PSAs) for transdermal therapy systems, which effectively combine the leading properties of acrylic and silicone polymers in a versatile adhesive family for patch development. Dow Corning is also showcasing a unique and innovative range of silicone-based topical ingredients that can be used in many different forms to manage acne. With their enhanced spreading capabilities, sensory properties and long-lasting effects, these ingredients can help customers create novel and efficacious approaches to acne management.

“Transdermal and topical drug delivery systems must ensure proper drug loading, stability and release,” said Gary Lord, global strategic marketing director, healthcare, Dow Corning. “Dow Corning supports evolving industry requirements by continuing to expand our silicone-based solutions for drug delivery and consumer healthcare applications. We have enhanced our BIO-PSA family with a single-technology hybrid solution that addresses multiple needs for patch formulators and pharmaceutical companies. Also, we are offering formulators new concepts for the growing market in OTC acne management. Through innovation and collaboration, Dow Corning is helping the industry achieve its current and future goals.”

Dow Pharma Solutions is highlighting its latest innovations for solubility enhancement and productivity enhancement, including: AFFINISOL™ HPMC HME, a new grade of hydroxypropyl methycellulose with improved thermal properties designed to solve the insoluble through hot melt extrusion without plasticizers; AFFINISOL™ hypromellose acetate succinate (HPMCAS), designed for solubility enhancement and available in standard and custom quality by design options to best match the needs of the active pharmaceutical ingredient (API); ETHOCEL™ High Productivity polymers for high-speed dry powder layering processes, which coat up to 70 percent faster than current multi-particulate coating technologies without the use of solvents; and METHOCEL™ DC2 for dry powder processing techniques, which help shorten development time and can reduce manufacturing costs by up to 60 percent.

Dow and Dow Corning already have a solid platform to build on: 73 years of shared history, shared values, and the same passion for innovation and customer focus. Dow Corning's silicones business reinforces Dow Pharma Solutions’ offering for topical, transdermal applications, as well as in transdermal, topical and oral gastroenterology. The relationship also enables Dow to provide complementary technology offerings in attractive industry segments, such as medical devices, where Dow Corning is already a leader.

“Separately, Dow and Dow Corning were experts in drug delivery, but coming together truly deepens, broadens and strengthens our expertise,” said Dago Caceres, global marketing leader for Dow Pharma Solutions. “Strong synergies between our two organizations provide access to expanded resources, services and technologies, including additional research and development capabilities.” Together, the Dow and Dow Corning teams’ expanded portfolio offerings now include tablets, capsules, liquids, semi-liquids, and topical and transdermal applications, and process technologies for hot melt extrusion, spray-dry dispersion, direct compression and bioprocessing.

The Dow and Dow Corning teams are presenting research posters on the following topics, and are available to answer questions:

  • “Defining Formulation Best Practices for a Direct Compression Grade of Hydroxypropyl Methylcellulose” on Monday, Nov. 14 at 12:00 p.m. in Terminal 31
  • “Evaluation of AFFINISOL™ Polymer by Top Spray Granulation Technology to Increase the Solubility of Class II Drug” on Monday, Nov. 14 at 3:00 p.m. in Terminal 32
  • “Prediction of Tablet Dissolution from API and Poly(Ethylene Oxide) Properties” on Tuesday, Nov. 15 at 12:00 p.m. in Terminal 32
  • “Defining Formulation Best Practices for a Direct Compression Grade of Hydroxypropyl Methylcellulose” on Tuesday, Nov. 15 at 12:00 p.m. in Terminal 29
  • “Formulation Performance and Stability of Hydroxypropyl Methylcellulose Acetate Succinate Designed for Hot Melt Extrusion” on Thursday, Nov. 17 at 11:00 a.m. in Terminal 34
  • “Melt Rheology of Cellulose Ethers Designed for Hot Melt Extrusion via In-Line Rheological Analysis” on Thursday, Nov. 17 at 12:00 p.m. in Terminal 27

For more information on these exciting technologies, visit Dow and Dow Corning’s booth #1321 and dowpharmasolutions.com or dowcorning.com. Scientists and application specialists will be on hand to discuss product and formulation questions.

About Dow Pharma & Food Solutions

Dow Pharma & Food Solutions designs differentiated solutions that enable pharmaceutical delivery & nutritional benefits to customers around the world. A business of Dow Consumer Care portfolio, Dow Pharma & Food Solutions offers a single interface to all Dow technologies and expertise focused on solutions serving the pharmaceutical and food manufacturing markets. We provide functional excipients, active pharmaceutical ingredients (APIs) and highly functional food ingredients to help consumers live healthier, more convenient and enjoyable lives. Dow Pharma & Food Solutions employs 1,200 people across nine sites and 15 manufacturing plants, with six cGMPs, serving customers in around 160 countries.

About Dow

Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from material, polymer, chemical and biological science to help address many of the world's most challenging problems such as the need for clean water, clean energy generation and conservation, and increasing agricultural productivity. Dow's integrated, market-driven, industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 180 countries and in high-growth sectors such as packaging, electronics, water, coatings and agriculture. In 2015, Dow had annual sales of nearly $49 billion and employed approximately 49,500 people worldwide. The Company's more than 6,000 product families are manufactured at 179 sites in 35 countries across the globe. On June 1, 2016, Dow became the 100 percent owner of Dow Corning Corporation’s silicones business, a global company with sales of greater than $4.5 billion in 2015, 25 manufacturing sites in 9 countries and approximately 10,000 employees worldwide. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.

Follow The Dow Chemical Company on Twitter: https://twitter.com/DowChemical
Follow The Dow Chemical Company on LinkedIn: http://www.linkedin.com/company/dow-chemical
Follow The Dow Chemical Company on Facebook: https://www.facebook.com/TheDowChemicalCompany

About Dow Corning

Dow Corning (dowcorning.com), a wholly owned subsidiary of The Dow Chemical Company, provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide. A global leader in silicones, silicon-based technology and innovation, Dow Corning offers more than 7,000 products and services via the company’s Dow Corning® and XIAMETER® brands. More than half of Dow Corning’s annual sales are outside the United States. Dow Corning’s global operations adhere to the American Chemistry Council’s Responsible Care® initiative, a stringent set of standards designed to advance the safe and secure management of chemical products and processes.

Follow Dow Corning on Twitter: twitter.com/dowcorning
Follow Dow Corning on LinkedIn: https://www.linkedin.com/company/dow-corning
Visit Dow Corning’s YouTube channel: youtube.com/dowcorningcorp

###

® Dow Corning is a registered trademark of Dow Corning Corporation. The Corning portion of the Dow Corning trademark is a trademark of Corning Incorporated, used under license.
© 2016 Dow Corning Corporation, a wholly owned subsidiary of The Dow Chemical Company. All rights reserved.
® Responsible Care is a registered service mark of the American Chemistry Council, Inc.

###

For further information contact:

Kelly Serke
Dow Pharma & Food Solutions
+1.267.441.2440
kkserke@dow.com
Brittney Quider
Dow Corning
+1.989.496.5933
brittney.quider@dowcorning.com
Aaron Wood
AH&M Marketing Communications
+1.413.448.2260, Extension 470
awood@ahminc.com